[ad_1] The first and only dual-acting interleukin-23 inhibitor approved in active ulcerative colitis, TREMFYA® showed highly statistically significant rates of endoscopic remission at one year in the pivotal QUASAR program1,2,3,4,5 TREMFYA® is now approved for the treatment […]
Trending Stories
Commercial Clay Marketplace to Develop through USD 2.16 Billion (2024-2028), Pushed through Increasing Development Trade, AI-Powered Research- Technavio
[ad_1] NEW YORK, Sep 11, 2024 /PRNewswire/ — File on how AI is using marketplace transformation- The worldwide commercial clay marketplace dimension is estimated to develop through USD 2.16 billion from 2024-2028, in line with […]
Okuma America Corporation Announces New Global Service and Repair Facility
[ad_1] Expanding the Company’s Capacity to Support Customers CHICAGO, Sept. 11, 2024 /PRNewswire/ — The executive leadership team at Okuma America Corporation is pleased to announce their plans to construct a new global service and […]
Vimaan Named within the Gartner® Hype Cycle™ Reviews, 2024 for Independent Knowledge Assortment and Inspection
[ad_1] SAN JOSE, Calif., Sep 11, 2024 /PRNewswire/ — Vimaan, the chief supplier of AI-enabled computer vision solutions for warehouse stock monitoring and visibility, lately introduced that it has as soon as once more been […]
Functional Powder Drink Concentrates Market to Grow by USD 903.7 Million (2024-2028) Driven by Rising Health Awareness, AI’s Impact- Technavio Report
[ad_1] NEW YORK, Sept. 11, 2024 /PRNewswire/ — Report with the AI impact on market trends- The global functional powder drinks concentrates market size is estimated to grow by USD 903.7 million from 2024-2028, according to […]














